Literature DB >> 25627684

Uncleaved ApoM signal peptide is required for formation of large ApoM/sphingosine 1-phosphate (S1P)-enriched HDL particles.

Mingxia Liu1, Jeremy Allegood2, Xuewei Zhu1, Jeongmin Seo1, Abraham K Gebre1, Elena Boudyguina1, Dongmei Cheng1, Chia-Chi Chuang1, Gregory S Shelness3, Sarah Spiegel2, John S Parks4.   

Abstract

Apolipoprotein M (apoM), a plasma sphingosine 1-phosphate (S1P) carrier, associates with plasma HDL via its uncleaved signal peptide. Hepatocyte-specific apoM overexpression in mice stimulates formation of both larger nascent HDL in hepatocytes and larger mature apoM/S1P-enriched HDL particles in plasma by enhancing hepatic S1P synthesis and secretion. Mutagenesis of apoM glutamine 22 to alanine (apoM(Q22A)) introduces a functional signal peptidase cleavage site. Expression of apoM(Q22A) in ABCA1-expressing HEK293 cells resulted in the formation of smaller nascent HDL particles compared with wild type apoM (apoM(WT)). When apoM(Q22A) was expressed in vivo, using recombinant adenoviruses, smaller plasma HDL particles and decreased plasma S1P and apoM were observed relative to expression of apoM(WT). Hepatocytes isolated from both apoM(WT)- and apoM(Q22A)-expressing mice displayed an equivalent increase in cellular levels of S1P, relative to LacZ controls; however, relative to apoM(WT), apoM(Q22A) hepatocytes displayed more rapid apoM and S1P secretion but minimal apoM(Q22A) bound to nascent lipoproteins. Pharmacologic inhibition of ceramide synthesis increased cellular sphingosine and S1P but not medium S1P in both apoM(WT) and apoM(Q22A) hepatocytes. We conclude that apoM secretion is rate-limiting for hepatocyte S1P secretion and that its uncleaved signal peptide delays apoM trafficking out of the cell, promoting formation of larger nascent apoM- and S1P-enriched HDL particles that are probably precursors of larger apoM/S1P-enriched plasma HDL.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Apolipoprotein M; Ceramide; Cholesterol; Fumonisin B1; High Density Lipoproteins; Liver; Myriocin; Sphingolipid; Sphingosine 1-Phosphate (S1P)

Mesh:

Substances:

Year:  2015        PMID: 25627684      PMCID: PMC4367285          DOI: 10.1074/jbc.M114.631101

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

Review 1.  High-density lipoprotein--the clinical implications of recent studies.

Authors:  D J Gordon; B M Rifkind
Journal:  N Engl J Med       Date:  1989-11-09       Impact factor: 91.245

2.  ApoA-I secretion from HepG2 cells: evidence for the secretion of both lipid-poor apoA-I and intracellularly assembled nascent HDL.

Authors:  Jeffrey W Chisholm; Ellen R Burleson; Gregory S Shelness; John S Parks
Journal:  J Lipid Res       Date:  2002-01       Impact factor: 5.922

Review 3.  Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities.

Authors:  Anatol Kontush; M John Chapman
Journal:  Curr Opin Lipidol       Date:  2010-08       Impact factor: 4.776

4.  Targeted deletion of hepatocyte ABCA1 leads to very low density lipoprotein triglyceride overproduction and low density lipoprotein hypercatabolism.

Authors:  Soonkyu Chung; Jenelle M Timmins; Myngan Duong; Chiara Degirolamo; Shunxing Rong; Janet K Sawyer; Roshni R Singaraja; Michael R Hayden; Nobuyo Maeda; Lawrence L Rudel; Gregory S Shelness; John S Parks
Journal:  J Biol Chem       Date:  2010-02-23       Impact factor: 5.157

5.  Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity.

Authors:  R C Sorenson; C L Bisgaier; M Aviram; C Hsu; S Billecke; B N La Du
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-09       Impact factor: 8.311

6.  apoA-IV tagged with the ER retention signal KDEL perturbs the intracellular trafficking and secretion of apoB.

Authors:  James W Gallagher; Richard B Weinberg; Gregory S Shelness
Journal:  J Lipid Res       Date:  2004-07-16       Impact factor: 5.922

7.  Killing of trypanosomes by the human haptoglobin-related protein.

Authors:  A B Smith; J D Esko; S L Hajduk
Journal:  Science       Date:  1995-04-14       Impact factor: 47.728

8.  Lipids and risk of coronary heart disease. The Framingham Study.

Authors:  W P Castelli; K Anderson; P W Wilson; D Levy
Journal:  Ann Epidemiol       Date:  1992 Jan-Mar       Impact factor: 3.797

9.  Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion.

Authors:  Melissa A VerHague; Dongmei Cheng; Richard B Weinberg; Gregory S Shelness
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-09-12       Impact factor: 8.311

10.  Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate.

Authors:  Nitai C Hait; Jeremy Allegood; Michael Maceyka; Graham M Strub; Kuzhuvelil B Harikumar; Sandeep K Singh; Cheng Luo; Ronen Marmorstein; Tomasz Kordula; Sheldon Milstien; Sarah Spiegel
Journal:  Science       Date:  2009-09-04       Impact factor: 47.728

View more
  13 in total

Review 1.  Sphingosine kinase and sphingosine-1-phosphate in liver pathobiology.

Authors:  Timothy Rohrbach; Michael Maceyka; Sarah Spiegel
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-06-15       Impact factor: 8.250

Review 2.  Sphingosine-1-phosphate metabolism: A structural perspective.

Authors:  Michael J Pulkoski-Gross; Jane C Donaldson; Lina M Obeid
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-04-29       Impact factor: 8.250

3.  Apolipoprotein M and Sphingosine-1-Phosphate Receptor 1 Promote the Transendothelial Transport of High-Density Lipoprotein.

Authors:  Srividya Velagapudi; Lucia Rohrer; Francesco Poti; Jerzy-Roch Nofer; Arnold von Eckardstein; Renate Feuerborn; Damir Perisa; Dongdong Wang; Grigorios Panteloglou; Anton Potapenko; Mustafa Yalcinkaya; Andreas J Hülsmeier; Bettina Hesse; Alexander Lukasz; Mingxia Liu; John S Parks; Christina Christoffersen; Markus Stoffel; Manuela Simoni
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-08-19       Impact factor: 10.514

Review 4.  The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases.

Authors:  Masayuki Nagahashi; Kizuki Yuza; Yuki Hirose; Masato Nakajima; Rajesh Ramanathan; Nitai C Hait; Phillip B Hylemon; Huiping Zhou; Kazuaki Takabe; Toshifumi Wakai
Journal:  J Lipid Res       Date:  2016-07-26       Impact factor: 5.922

5.  Resveratrol exerts a biphasic effect on apolipoprotein M.

Authors:  Makoto Kurano; Masumi Hara; Takahiro Nojiri; Hitoshi Ikeda; Kazuhisa Tsukamoto; Yutaka Yatomi
Journal:  Br J Pharmacol       Date:  2015-11-12       Impact factor: 8.739

Review 6.  AIBP, Angiogenesis, Hematopoiesis, and Atherogenesis.

Authors:  Xueting Qiu; Jingmin Luo; Longhou Fang
Journal:  Curr Atheroscler Rep       Date:  2020-11-24       Impact factor: 5.113

7.  Binding Characteristics of Sphingosine-1-Phosphate to ApoM hints to Assisted Release Mechanism via the ApoM Calyx-Opening.

Authors:  Hansi Zhang; Kristyna Pluhackova; Zhenyan Jiang; Rainer A Böckmann
Journal:  Sci Rep       Date:  2016-08-01       Impact factor: 4.379

8.  HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium.

Authors:  Mario Ruiz; Hiromi Okada; Björn Dahlbäck
Journal:  Lipids Health Dis       Date:  2017-02-08       Impact factor: 3.876

Review 9.  A Novel Perspective on the ApoM-S1P Axis, Highlighting the Metabolism of ApoM and Its Role in Liver Fibrosis and Neuroinflammation.

Authors:  Stefan Hajny; Christina Christoffersen
Journal:  Int J Mol Sci       Date:  2017-07-27       Impact factor: 5.923

10.  A Chimeric Signal Peptide-Galectin-3 Conjugate Induces Glycosylation-Dependent Cancer Cell-Specific Apoptosis.

Authors:  Sok-Hyong Lee; Fatima Khwaja Rehman; Kari C Tyler; Bing Yu; Zhaobin Zhang; Satoru Osuka; Abdessamad Zerrouqi; Milota Kaluzova; Costas G Hadjipanayis; Richard D Cummings; Jeffrey J Olson; Narra S Devi; Erwin G Van Meir
Journal:  Clin Cancer Res       Date:  2020-01-22       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.